Artificial intelligence and assisted reproductive technology: A comprehensive systematic review.

Journal: Taiwanese journal of obstetrics & gynecology
PMID:

Abstract

The objective of this review is to evaluate the contributions of Artificial Intelligence (AI) to Assisted Reproductive Technologies (ART), focusing on its role in enhancing the processes and outcomes of fertility treatments. This study analyzed 48 relevant articles to assess the impact of AI on various aspects of ART, including treatment efficacy, process optimization, and outcome prediction. The effectiveness of different machine learning paradigms-supervised, unsupervised, and reinforcement learning-in improving ART-related procedures was particularly examined. The findings indicate that AI technologies significantly enhance ART processes by refining tasks such as embryo and sperm analysis and facilitating personalized treatment plans based on predictive modeling. Notable improvements were observed in the accuracy of diagnosing and predicting successful outcomes in fertility treatments. AI-driven models provided more precise forecasts of the optimal timing for clinical interventions such as egg retrieval and embryo transfer, which are critical to the success of ART cycles. The integration of AI into ART represents a transformative advancement, substantially improving the precision and efficiency of fertility treatments. The continuous evolution of AI methodologies is likely to further revolutionize this field, enabling more tailored and successful treatment approaches. AI is becoming an indispensable tool in reproductive medicine, enhancing both the effectiveness of treatments and the clinical decision-making process. This review underscores the potential of AI to act as a catalyst for innovative solutions in the optimization of ART.

Authors

  • Yen-Chen Wu
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei, Taiwan; Graduate Institute of Biomedical Informatics, Taipei Medical University, Taipei, Taiwan.
  • Emily Chia-Yu Su
    Graduate Institute of Biomedical Informatics, College of Medicine Science and Technology, Taipei Medical University, Taipei, Taiwan.
  • Jung-Hsiu Hou
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei, Taiwan; Graduate Institute of Medical Science, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Ching-Jung Lin
    Graduate Institute of Biomedical Informatics, Taipei Medical University, Taipei, Taiwan; Department of Obstetrics and Gynecology, Taipei Medical University Shuang Ho Hospital, Taipei, Taiwan.
  • Krystal Baysan Lin
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei, Taiwan.
  • Chi-Huang Chen
    Division of Reproductive Medicine, Department of Obstetrics and Gynecology, Taipei Medical University Hospital, Taipei, Taiwan; Department of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Electronic address: d102095012@gmail.com.